• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Intra-articular corticosteroids unlikely to benefit osteoarthritis patients

byDaniel FisherandMichael Milligan
May 23, 2017
in Chronic Disease, Imaging and Intervention, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this double blind, randomized controlled trial, intra-articular triamcinolone injections did not prevent cartilage degeneration compared to saline injection controls.

2. Triamcinolone injections did not improve patients’ pain from osteoarthritis compared to controls.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Osteoarthritis is a leading cause of disability in the United States. The condition leads to significant medical costs, due in part to a high rate of knee arthroplasty. As the pathogenesis of osteoarthritis is largely considered to be inflammatory, reducing inflammation at the joint may slow disease progression and improve symptoms. In this double-blind, randomized controlled trial, patients with osteoarthritis were given either intra-articular injections of triamcinolone or saline every 3 months for two years. Surprisingly, assessments showed moderate but significant reductions in cartilage thickness for the triamcinolone-treated group compared to saline-treated controls, though other measures such as cartilage denudation, marrow lesion, effusion volume, or changes in trabecular morphology were not significantly different. There was no decrease in knee pain or other patient-reported symptoms. Though some significant differences between groups in adverse events were reported, the number that was due to the treatment itself were likely to be similar. As such this trial does not support the use of intra-articular steroids as a treatment for osteoarthritis.

Click to read the study, published in JAMA

Relevant Reading: Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial

In-Depth [randomized controlled trial]: In total, 140 patients with osteoarthritis were split evenly into triamcinolone and saline groups. Intra-articular injections of either compound were given every 3 months for 2 years. About 85% of patients in each group completed the study and had complete records with radiographs, ultrasonography, x-ray absorptiometry, and MRI used for quantitative assessments of joint health. Triamcinolone caused a decrease in cartilage thickness (-0.11 mm; CI95 -0.20 to -0.03 mm) and an increase in the secondary cartilage damage index (-61.25 μm3; CI95 -121.78 to -0.72 μm3). There were no significant differences between groups for cartilage denudation, bone marrow lesions, effusion volume, or changes in trabecular morphology (p > 0.05). There was no change in the subchondral tibia or hip and in bone mineral densities between groups. While there were more adverse effects in the saline treated group (p = 0.02), there were 3 treatment related effects in the saline group compared to 5 treatment related effects in the triamcinolone group, suggesting that adverse effect differences were likely due to chance. There was no difference in serious adverse effects.

RELATED REPORTS

Knee extensor muscle weakness may be a risk factor for osteoarthritis

Wellness Check: Exercise

#VisualAbstract: Addition of itacitinib to corticosteroids did not show clinical benefit over placebo in initial treatment of acute graft-versus-host disease

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: corticosteroidsosteoarthritis
Previous Post

No beneficial effects of oral iron repletion in patients with heart failure and iron deficiency

Next Post

2 Minute Medicine Rewind May 22, 2017

RelatedReports

Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Knee extensor muscle weakness may be a risk factor for osteoarthritis

February 2, 2022
Adolescents’ muscle strength associated with lower cardiometabolic risk
Wellness

Wellness Check: Exercise

January 27, 2022
#VisualAbstract: Addition of itacitinib to corticosteroids did not show clinical benefit over placebo in initial treatment of acute graft-versus-host disease
StudyGraphics

#VisualAbstract: Addition of itacitinib to corticosteroids did not show clinical benefit over placebo in initial treatment of acute graft-versus-host disease

January 6, 2022
#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation
StudyGraphics

#VisualAbstract: The use of COVID-19 convalescent plasma not beneficial to patients hospitalized with COVID-19

December 23, 2021
Next Post
Live attenuated vaccine less effective in recent influenza season

2 Minute Medicine Rewind May 22, 2017

Delays in surgical intervention do not increase odds of appendiceal perforation

Delays in surgical intervention do not increase odds of appendiceal perforation

Development of a risk index for colorectal cancer screening

Despite screening, black persons far more likely than whites to be diagnosed with colon cancer

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.